AVR — Anteris Technologies Income Statement
0.000.00%
Last trade - 00:00HealthcareAdventurousSmall CapNeutral
- AU$361.05m
- AU$333.58m
- AU$9.27m
- 64
- 11
- 50
- 39
Annual income statement for Anteris Technologies, fiscal year end - December 31st, AUD millions except per share, conversion factor applied.
2017 June 30th | 2018 December 31st | 2019 December 31st | 2020 December 31st | 2021 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 22.5 | 25.7 | 17.2 | 9.57 | 9.27 |
| Cost of Revenue | |||||
| Gross Profit | 10.9 | 12.5 | 8.38 | 6.84 | 7.63 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 35.2 | 50.4 | 23.3 | 24.8 | 30.8 |
| Operating Profit | -12.7 | -24.7 | -6.18 | -15.3 | -21.5 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -12.7 | -24.7 | -6.18 | -15.3 | -22.9 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -12.7 | -24.7 | -6.18 | -15.3 | -22.9 |
| Minority Interest | |||||
| Net Income Before Extraordinary Items | |||||
| Net Income | -12.3 | -24.2 | -5.82 | -15.3 | -22.9 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -12.3 | -24.2 | -5.82 | -15.3 | -22.9 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -4.72 | -7.93 | -4.56 | -2.58 | -3.09 |